Cited by 94Gallbladder and Bile Duct DisordersSepsis Diagnosis and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies

The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock.

Open access
Karvellas, C. J., Abraldes, J. G., Zepeda‐Gomez, S., Moffat, D. C., Mirzanejad, Y., Vazquez‐Grande, G., Esfahani, E. K., Kumar, A. +1 more·2016·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Cholangitis‐associated septic shock carries significant mortality. There is uncertainty regarding the most appropriate time to achieve biliary decompression. Aim: To determine whether the timing of biliary decompression and anti‐microbial therapy affect the survival in cholangitis patients with septic shock. Methods: Nested retrospective cohort study of all cholangitis‐associated septic shock patients (hypotension requiring vasopressors) from an international, multi‐centre database between 1996 and 2011. Results: Among 260 patients (mean age 69 years, 57% male), overall mortality was 37%. Compared to nonsurvivors (n = 96), survivors (n = 164) had lower mean admission Acute Physiology And Chronic Health Evaluation (APACHE) II (22 vs. 28, P < 0.001) and lower median serum lactate on admission (3.4 vs. 4.6 mmol/L, P < 0.001). Survivors were more likely to receive appropriate anti‐microbial therapy earlier (median 2.6 vs. 6.8 h from shock, P < 0.001). Survivors were also more likely to undergo successful biliary decompression earlier (median 8.8 vs. 22 h, P < 0.001). After adjusting for co‐variates, APACHE II (odds ratio, OR 1.21 per increment (1.11–1.32), time delay to appropriate anti‐microbial therapy [OR 1.15 per hour (1.07–1.25)] and delayed biliary decompression >12 h [OR 3.40 (1.12–10.31)] were all significantly associated with increased mortality (P < 0.04 for all; c‐statistic 0.896). Conclusions: Patients with septic shock secondary to acute cholangitis have significant mortality. Endoscopic biliary decompression >12 h after the onset of shock and delayed receipt of appropriate anti‐microbial therapy were both significantly associated with adverse hospital outcome. This might suggest that early initiation of anti‐microbial therapy and urgent biliary decompression (within 12 h) could potentially improve outcomes in this high‐risk patient population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13764

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 37 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Karvellas, C. J., Abraldes, J. G., Zepeda‐Gomez, S., Moffat, D. C., Mirzanejad, Y., Vazquez‐Grande, G., Esfahani, E. K., Kumar, A., & the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group
Affiliations
  • University of Alberta (CA)
  • Division of Gastroenterology and Hepatology University of Alberta Edmonton AB Canada
  • University of Manitoba (CA)
  • Surrey Memorial Hospital (CA)
  • Section of Critical Care Medicine University of Manitoba Winnipeg MB Canada
Corresponding author
Karvellas, C. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2016-08-10
Volume
44
Issue
7
Pages
755-766
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2479308360
Cited by
94
References
37
Citations by year
2026: 2 · 2025: 5 · 2024: 6 · 2023: 14 · 2022: 10 · 2021: 26 · 2020: 11 · 2019: 13 · 2018: 2 · 2017: 5
FWCI
5.96
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gallbladder and Bile Duct Disorders
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
Keywords
cholangitis, septic shock, biliary decompression, endoscopic biliary drainage, antimicrobial therapy timing, mortality, APACHE II score, serum lactate, vasopressors, prognostic factors
MeSH terms
Acute Disease, Aged, Aged, 80 and over, Cholangitis, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, Shock, Septic, Vasoconstrictor Agents, Odds Ratio, APACHE

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review